These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 25555268)
1. Circulating gamma glutamyltransferase and prediction of cardiovascular disease. Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268 [TBL] [Abstract][Full Text] [Related]
2. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717 [TBL] [Abstract][Full Text] [Related]
3. Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study. Kunutsor SK; Bakker SJL; Dullaart RPF J Atheroscler Thromb; 2017 Aug; 24(8):804-818. PubMed ID: 28202840 [TBL] [Abstract][Full Text] [Related]
4. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys. Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154 [TBL] [Abstract][Full Text] [Related]
5. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H; Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419 [TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies. Kunutsor SK; Bakker SJ; James RW; Dullaart RP Atherosclerosis; 2016 Feb; 245():143-54. PubMed ID: 26724525 [TBL] [Abstract][Full Text] [Related]
7. Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study. Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Blokzijl H; Gansevoort RT; Dullaart RP Atherosclerosis; 2015 Nov; 243(1):138-47. PubMed ID: 26386210 [TBL] [Abstract][Full Text] [Related]
8. γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study. Kunutsor SK; Khan H; Laukkanen JA J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857068 [TBL] [Abstract][Full Text] [Related]
10. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study. Velescu A; Clara A; Peñafiel J; Ramos R; Marti R; Grau M; Dégano IR; Marrugat J; Elosua R; Atherosclerosis; 2015 Aug; 241(2):357-63. PubMed ID: 26071658 [TBL] [Abstract][Full Text] [Related]
11. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Wannamethee SG; Lennon L; Shaper AG Atherosclerosis; 2008 Nov; 201(1):168-75. PubMed ID: 18378241 [TBL] [Abstract][Full Text] [Related]
12. Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus. Sluik D; Beulens JW; Weikert C; van Dieren S; Spijkerman AM; van der A DL; Fritsche A; Joost HG; Boeing H; Nöthlings U Diabetes Metab Res Rev; 2012 Mar; 28(3):284-8. PubMed ID: 22144398 [TBL] [Abstract][Full Text] [Related]
13. gamma-Glutamyltransferase predicts cardiovascular death among Japanese women. Hozawa A; Okamura T; Kadowaki T; Murakami Y; Nakamura K; Hayakawa T; Kita Y; Nakamura Y; Okayama A; Ueshima H; Atherosclerosis; 2007 Oct; 194(2):498-504. PubMed ID: 17034795 [TBL] [Abstract][Full Text] [Related]
14. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies. Kunutsor SK; Apekey TA; Khan H Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934 [TBL] [Abstract][Full Text] [Related]
15. Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein. Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Gregson J; Dullaart RP PLoS One; 2015; 10(7):e0132822. PubMed ID: 26167920 [TBL] [Abstract][Full Text] [Related]
16. Gamma-glutamyltransferase and cardiovascular mortality in Korean adults: A cohort study. Yi SW; Lee SH; Hwang HJ; Yi JJ Atherosclerosis; 2017 Oct; 265():102-109. PubMed ID: 28881267 [TBL] [Abstract][Full Text] [Related]
17. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Mora S; Rifai N; Buring JE; Ridker PM Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722 [TBL] [Abstract][Full Text] [Related]
18. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Kunutsor SK; Bakker SJ; Gansevoort RT; Chowdhury R; Dullaart RP Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):716-24. PubMed ID: 25593130 [TBL] [Abstract][Full Text] [Related]
19. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants. Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883 [TBL] [Abstract][Full Text] [Related]
20. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Meisinger C; Döring A; Schneider A; Löwel H; Atherosclerosis; 2006 Dec; 189(2):297-302. PubMed ID: 16483579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]